Development · 19 Sep 2026

The Food Safety and Standards Authority of India (FSSAI) has initiated three adjudication cases against Nestle India concerning compliance issues related to its infant nutrition products.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

livemint.com18 Sep 2026

A single act of reporting so far, corroborating sources join this record as they publish.

Nestle India

₹1,307.70

▼ -0.18%

Close (EOD), as of 1 Oct 2026 · source

Nestle India: results, dividends, orders, the full cited record →

More on Nestle India

Nestle India's Board of Directors is scheduled to meet on October 15 to consider the unaudited consolidated and standalone financial results for Q2FY27.

25 Sep 2026 · 1 publisher

Several stocks are likely to remain in focus on Monday, September 21, following order wins, fundraising plans, dividend-related developments, acquisitions and other corporate updates.

21 Sep 2026 · 1 publisher

Nestle India's shares fell around 3% on September 18 after the FSSAI launched legal action over multiple food safety violations, filing cases regarding three products after laboratory tests failed to meet Biotin requirements.

19 Sep 2026 · 1 publisher

Nestle India shares fell nearly 3% after the Food Safety and Standards Authority of India initiated legal action over alleged non-compliance involving its NAN Excella Pro Stage 1 and Lactogen Pro 1 infant nutrition products.

18 Sep 2026 · 1 publisher

Nestle India's overall outlet reach has risen to about 6.2 million outlets from 5.7 million in 2023.

16 Sep 2026 · 1 publisher

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.